1. Home
  2. ACNB vs SLDB Comparison

ACNB vs SLDB Comparison

Compare ACNB & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACNB Corporation

ACNB

ACNB Corporation

HOLD

Current Price

$47.93

Market Cap

492.4M

Sector

Finance

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$7.45

Market Cap

498.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACNB
SLDB
Founded
1857
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.4M
498.6M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
ACNB
SLDB
Price
$47.93
$7.45
Analyst Decision
Buy
Strong Buy
Analyst Count
1
11
Target Price
$52.00
$16.36
AVG Volume (30 Days)
46.5K
1.6M
Earning Date
04-23-2026
05-14-2026
Dividend Yield
3.17%
N/A
EPS Growth
N/A
34.97
EPS
3.60
N/A
Revenue
$191,821,000.00
$8,094,000.00
Revenue This Year
$13.18
N/A
Revenue Next Year
$1.91
N/A
P/E Ratio
$13.33
N/A
Revenue Growth
45.10
N/A
52 Week Low
$36.40
$2.45
52 Week High
$53.89
$8.47

Technical Indicators

Market Signals
Indicator
ACNB
SLDB
Relative Strength Index (RSI) 49.95 55.08
Support Level $47.43 $5.16
Resistance Level $49.13 $7.55
Average True Range (ATR) 1.14 0.59
MACD 0.29 -0.03
Stochastic Oscillator 87.11 68.55

Price Performance

Historical Comparison
ACNB
SLDB

About ACNB ACNB Corporation

ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: